Tele Health Monitoring Service for Patients With Chronic Obstructive Pulmonary Disease
Study Details
Study Description
Brief Summary
The aim of this study is to evaluate the effect of monitoring patients with chronic obstructive pulmonary disease (COPD) after a hospitalization for COPD exacerbation or pneumonia. The patients are randomized to receive either standard treatment and follow up, or standard treatment and follow up, plus tele monitoring of key clinical parameters and symptoms for six months.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Telemedicine is a relatively new approach for the management of chronic obstructive pulmonary disease (COPD) disease. Telemedicine, for monitoring disease exacerbation, is the focus area of our research. The patient monitoring offers the possibility of early initiation of treatment of patients who has evidence of COPD exacerbation or pulmonary infection. The self-monitoring of potential exacerbation is started after a hospitalization, and is done by the patient on a daily (not on weekends) basis initially. After one month the monitoring is made at least three times weekly during the rest of the intervention period of six months. With the help of the monitoring equipment, the patient answers a short series of health related questions, and makes simple measurements of oxygen saturation, heart rate, lung function and weight. Data is sent to the hospital, and here the staff can assess the data and respond to them the same day, with a phone call to the patient, if the patient's condition has changed. The selected telemonitoring-equipment, consists of a monitoring systems for the assessment of key clinical parameters and symptoms. All patients, in the intervention group as well as in the control group, are trained in the use of a standardized self-treatment plan. It is expected that the monitoring of symptoms and signs will support patient empowerment.
The investigation is planned to assess the clinical and economic effects of the intervention.
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| No Intervention: Control Best practice |
|
| Experimental: Intervention Best practice + Tele Monitoring of physiological parameters (heart frequence, oxygen saturation, weight, FEV1), and answers to disease specific questions, using Tunstall monitoring device. |
Device: Tele Monitoring, using Tunstall monitoring device
Monitoring of symptoms and physiological parameters at home, using Tunstall Healthcare telemedicine equipment. Patients perform physiological measurement. In addition, they correspond to a standardized questionnaire regarding disease specific symptoms. Data is assessed by the medical staff the same day. If the data indicates worsening in the patient's condition, the patient is contacted by phone. The assessment of the patient is made either on the specialist nurse level, or at a conference between the specialist nurse and a senior pulmonary doctor. There is no call center service.
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Number of hospitalization days [During twelve months]
Secondary Outcome Measures
- Duration of COPD related hospitalizations, in days [Twelve months]
- Number of hospitalizations caused by COPD exacerbation [During twelve months]
- Number of COPD related contacts to emergency rooms [Twelve months]
- Number of self-addressed COPD exacerbations [Twelve months]
Without primary contact to medical staff
- Sensitivity of physiological measurements in detecting COPD exacerbation [During six months of intervention]
Relation between physiological measurements and COPD exacerbation
- Number of unplanned contact to primary health sector [Twelve months]
Contacts to general practitioner or Doctor on call in the primary health sector
- Health related quality of life [Twelve months]
Saint George´s respiratory questionnaire, Hospital Anxiety and Depression score, SF-36 questionnaire
- Number of all cause contacts to primary health sector [Twelve months]
Contacts to general practitioner or Doctor on call in the primary health sector
- Mortality [During twelve months]
Eligibility Criteria
Criteria
Inclusion Criteria:
- Chronic Obstructive Pulmonary Disease COPD with FEV1/FVC (Forced Expiratory Volume in 1 second / Forced Vital Capacity) below 70% at all times during the study. FEV1 below 51% during inclusion and during the further study. Inclusion takes place during a hospitalization, with exacerbation in pulmonary symptoms.
Exclusion Criteria:
-
Not able to give written or oral consent
-
Terminal disease, such as cancer
-
Unstable heart disease, such as coronary infarction within the last to month
-
Disabling psychiatric disease
-
Asthma
-
Inability to use the equipment
-
Severe language barriers
-
Drug abuse
-
Alcohol abuse
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Region Hospital of Silkeborg | Silkeborg | Mid Region | Denmark | 8600 |
Sponsors and Collaborators
- University of Aarhus
Investigators
- Principal Investigator: Frank D Andersen, MD, Diagnostic Center, Regional Hospital of Silkeborg
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- UAarhusFA